Track topics on Twitter Track topics that are important to you
212 Carnegie CenterSuite 101
United States of America
Kyowa Hakko Kirin Co. Ltd, (Kyowa Hakko Kirin), Kyowa Kirin International PLC (Kyowa Kirin International) und Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE: Ultragenyx) gaben Read more...
Kyowa Hakko Kirin Co. Ltd.MediaHiroki Nakamura, +firstname.lastname@example.org Read more...
TOKYO, LONDON, and NOVATO, California, December 15, 2017 /PRNewswire/ -- If approved, burosumabwould be the first targeted disease-modifying treatment for XLH Kyowa Hakko Kirin Co., Ltd. (Kyowa Ha...
Tokio, London, und Novato, Kalifornien (ots/PRNewswire) - Bei Zulassung wäre Burosumab die erste gezielte krankheitsmodifizierende Behandlung für XLH Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin)....
Tokio (ots/PRNewswire) - Die Kyowa Hakko Kirin Co., Ltd. (Tokio: 4151 President und CEO: Nobuo Hanai, "Kyowa Hakko Kirin" gibt heute bekannt, dass ihr Vermarktungszulassungsantrag (MAA) für Mogamul.....
TOKYO--(BUSINESS WIRE)-- November 28, 2017 Kyowa Hakko Kirin Co., Ltd. (TOKYO:4151) (President and CEO: Nobuo Hanai, “Kyowa Hakko Kirin”) today announces that the U.S. Food and Drug Administration...
TOKYO, December 11, 2017 /PRNewswire/ -- Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151, President and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") announced today that the results of the Global Phase 3 study...
Shares of Japanese drugmaker Kyowa Hakko Kirin moved up more than 2% to 2,086 yen today, after the company…
Cetirizine Hydrochloride Syrup
There are questions in the article that study mutual relations of patients of elderly and senile age with pharmaceutical experts. It was revealed that pharmacy organizations are an important element i...
The properties of many drugs which have been available on the pharmaceutical market for a long time still need to be improved. Cocrystals are the solid state drug modification which can improve such p...
This study aimed to examine a detailed breakdown of costs (absenteeism, presenteeism, and medical/pharmaceutical expenses), of the employees in four pharmaceutical companies in Japan.
Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) when the...
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...
The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...
The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...
The purpose of the study is to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant outpatients
From its foundation in 1949, Kyowa Hakko has been a global leader in the pharmaceutical industry. Today, Kyowa's expertise extends to the United States through Kyowa Pharmaceutical, Inc. headquartered...
We have published hundreds of Kyowa Pharmaceutical, Inc news stories on BioPortfolio along with dozens of Kyowa Pharmaceutical, Inc Clinical Trials and PubMed Articles about Kyowa Pharmaceutical, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kyowa Pharmaceutical, Inc Companies in our database. You can also find out about relevant Kyowa Pharmaceutical, Inc Drugs and Medications on this site too.